Health Up as Pfizer Slides -- Health Care Roundup
Health-care companies ticked up amid deal activity. Swiss drug giant Roche Holding agreed to buy California-based biotechnology company Carmot Therapeutics...
Source: marketwatch.com
📰 Rog Eb News
Page 2 - Rog Eb News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rog Eb. Real-time updates on events, politics, business and more.
Alabama Death-Row Inmate Fights Looming Use of New Execution Method
Kenneth Eugene Smith would be the first person in the U.S. to be executed by nitrogen hypoxia
Source: wsj.com
Roche Gets FDA Approval for Vabysmo as Retinal Vein Occlusion Treatment
By Adria Calatayud Roche Holding said it received approval from the U.S. Food and Drug Administration for Vabysmo as treatment of macular edema following...
Adria Calatayud Roche Holding Drug Administration For Vabysmo Drug Administration Article Normal Healthcare Life Sciences
Source: marketwatch.com
This $5 Billion Biotech Home Run Took Less Than a Year
Pfizer’s curious offloading of a drug that was quickly sold to a rival
Stefan Wermuth Bloomberg Vivek Ramaswamy Wall Street Journal Wsjfinance Markets Biotechnology Services Healthcare Life Sciences
Source: wsj.com
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
Swiss pharmaceutical giant seeks to bolster pipeline
Vivek Ramaswamy Philipp Schmidli Bloomberg Roivant Sciences Roche Holding Telavant Holdings Biotechnology Services
Source: wsj.com
Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Bln Deal
By Adria Calatayud Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion that will give it...
Adria Calatayud Roivant Sciences Roche Holding Telavant Holdings Article Normal Healthcare Life Sciences
Source: marketwatch.com
Roivant, Textainer, Okta, Microsoft, Alphabet, and More Stock Market Movers
Chevron will buy Hess in all-stock deal valued at $53 billion, Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease...
Wall Street Article Normal Metalworking Machinery Wooden Furniture Retail Wholesale Lodgings Restaurants Bars
Source: marketwatch.com
Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Bln -- Update
By Adria Calatayud Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion as the Swiss...
Source: marketwatch.com
Roche Backs 2023 View
By Adria Calatayud Roche Holding confirmed its 2023 guidance after a fall in sales for the first nine months, with growth in its pharmaceutical division...
Adria Calatayud Roche Holding Article Normal Healthcare Life Sciences Financial Performance Sales Figures
Source: marketwatch.com
Roche Shares Fall on Lower Sales Due to Currency Hit
By Adria Calatayud Shares in Roche Holding fell after the company reported lower sales for the first nine months and flagged a bigger hit from currency...
Eric Le Berrigaud Adria Calatayud Roche Holding Article Normal Healthcare Life Sciences Financial Performance
Source: marketwatch.com